| Product Code: ETC6753526 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
China small volume parenteral import shipments in 2024 saw top contributions from Puerto Rico, Metropolitan France, Germany, Spain, and Italy. The market continued to exhibit high concentration with a high Herfindahl-Hirschman Index (HHI). However, the industry experienced a negative Compound Annual Growth Rate (CAGR) of -2.06% from 2020 to 2024, with a significant decline in growth rate of -26.63% from 2023 to 2024. This data suggests a challenging landscape for small volume parenteral imports in China, highlighting the need for strategic adjustments and market analysis for stakeholders in the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Small Volume Parenteral Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Small Volume Parenteral Market Revenues & Volume, 2021 & 2031F |
3.3 China Small Volume Parenteral Market - Industry Life Cycle |
3.4 China Small Volume Parenteral Market - Porter's Five Forces |
3.5 China Small Volume Parenteral Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.6 China Small Volume Parenteral Market Revenues & Volume Share, By Dose Type, 2021 & 2031F |
3.7 China Small Volume Parenteral Market Revenues & Volume Share, By Packaging, 2021 & 2031F |
3.8 China Small Volume Parenteral Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 China Small Volume Parenteral Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in China leading to higher demand for small volume parenteral products. |
4.2.2 Growing geriatric population in China requiring more healthcare services including small volume parenteral products. |
4.2.3 Technological advancements in manufacturing processes leading to improved quality and efficiency of small volume parenteral products. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for small volume parenteral products in China. |
4.3.2 Competition from alternative drug delivery methods such as oral medications or large volume parenteral products. |
4.3.3 Price sensitivity among consumers and healthcare providers affecting the adoption of small volume parenteral products. |
5 China Small Volume Parenteral Market Trends |
6 China Small Volume Parenteral Market, By Types |
6.1 China Small Volume Parenteral Market, By Form |
6.1.1 Overview and Analysis |
6.1.2 China Small Volume Parenteral Market Revenues & Volume, By Form, 2021- 2031F |
6.1.3 China Small Volume Parenteral Market Revenues & Volume, By Liquid, 2021- 2031F |
6.1.4 China Small Volume Parenteral Market Revenues & Volume, By Dry, 2021- 2031F |
6.2 China Small Volume Parenteral Market, By Dose Type |
6.2.1 Overview and Analysis |
6.2.2 China Small Volume Parenteral Market Revenues & Volume, By Single-dose, 2021- 2031F |
6.2.3 China Small Volume Parenteral Market Revenues & Volume, By Multiple-dose, 2021- 2031F |
6.3 China Small Volume Parenteral Market, By Packaging |
6.3.1 Overview and Analysis |
6.3.2 China Small Volume Parenteral Market Revenues & Volume, By Ampoules, 2021- 2031F |
6.3.3 China Small Volume Parenteral Market Revenues & Volume, By Vials, 2021- 2031F |
6.3.4 China Small Volume Parenteral Market Revenues & Volume, By Pre-filled Syringes, 2021- 2031F |
6.3.5 China Small Volume Parenteral Market Revenues & Volume, By Cartridges, 2021- 2031F |
6.3.6 China Small Volume Parenteral Market Revenues & Volume, By Bottles, 2021- 2031F |
6.3.7 China Small Volume Parenteral Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Small Volume Parenteral Market, By Indication |
6.4.1 Overview and Analysis |
6.4.2 China Small Volume Parenteral Market Revenues & Volume, By Pain Management, 2021- 2031F |
6.4.3 China Small Volume Parenteral Market Revenues & Volume, By Cancer Care, 2021- 2031F |
6.4.4 China Small Volume Parenteral Market Revenues & Volume, By Malnourishment, 2021- 2031F |
6.4.5 China Small Volume Parenteral Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.4.6 China Small Volume Parenteral Market Revenues & Volume, By Others, 2021- 2031F |
7 China Small Volume Parenteral Market Import-Export Trade Statistics |
7.1 China Small Volume Parenteral Market Export to Major Countries |
7.2 China Small Volume Parenteral Market Imports from Major Countries |
8 China Small Volume Parenteral Market Key Performance Indicators |
8.1 Rate of adoption of small volume parenteral products in hospitals and clinics. |
8.2 Number of partnerships and collaborations between small volume parenteral manufacturers and healthcare providers in China. |
8.3 Percentage of RD investment in developing innovative small volume parenteral products. |
8.4 Patient satisfaction and feedback on the effectiveness and safety of small volume parenteral products. |
8.5 Percentage of market expansion into rural areas and smaller cities in China. |
9 China Small Volume Parenteral Market - Opportunity Assessment |
9.1 China Small Volume Parenteral Market Opportunity Assessment, By Form, 2021 & 2031F |
9.2 China Small Volume Parenteral Market Opportunity Assessment, By Dose Type, 2021 & 2031F |
9.3 China Small Volume Parenteral Market Opportunity Assessment, By Packaging, 2021 & 2031F |
9.4 China Small Volume Parenteral Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 China Small Volume Parenteral Market - Competitive Landscape |
10.1 China Small Volume Parenteral Market Revenue Share, By Companies, 2024 |
10.2 China Small Volume Parenteral Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here